Self-Assembled Nano-CT Contrast Agent Leveraging Size Aggregation for Improved In Vivo Tumor CT Imaging

© 2023 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 2 vom: 01. Jan., Seite e2309789
1. Verfasser: Wang, Chengcheng (VerfasserIn)
Weitere Verfasser: Zhu, Jingjing, Wang, Shasha, Zhao, Lingzhou, Wei, Peng, Yi, Tao
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article AIEgen aggregation function computed tomography imaging time window iodinated contrast agents Contrast Media
LEADER 01000caa a22002652 4500
001 NLM364635053
003 DE-627
005 20240114234258.0
007 cr uuu---uuuuu
008 231226s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202309789  |2 doi 
028 5 2 |a pubmed24n1257.xml 
035 |a (DE-627)NLM364635053 
035 |a (NLM)37971929 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Wang, Chengcheng  |e verfasserin  |4 aut 
245 1 0 |a Self-Assembled Nano-CT Contrast Agent Leveraging Size Aggregation for Improved In Vivo Tumor CT Imaging 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 12.01.2024 
500 |a Date Revised 12.01.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2023 Wiley-VCH GmbH. 
520 |a Computed tomography (CT) is a widely utilized noninvasive diagnostic tool in clinical practice. However, the commonly employed small molecular iodinated contrast agents (ICAs) in clinical CT imaging have limitations such as nonspecific distribution in body, rapid clearance through kidneys, etc., leading to a narrow imaging time window. In contrast, existing nano-sized ICAs face challenges like structural uncertainty, poor reproducibility, low iodine content, and uniformity issues. In this study, a novel approach is presented utilizing the aggregation-induced emission luminogen (AIEgen) to design and fabricate a kind of monocomponent nano-sized ICA (namely, BioDHU-CT NPs) that exhibits a unique aggregation effect upon activation. The small sized BioDHU-CT nanoparticles exhibit excellent tumor targeting capabilities and can release ICA modified with AIEgen with a high release efficiency up to 88.45%, under the activation of reactive oxygen species highly expressed in tumor regions. The released ICA performs in situ aggregation capability in the tumor region, which can enhance the retention efficiency of CT contrast agents, extending the imaging time window and improving the imaging quality in tumor regions 
650 4 |a Journal Article 
650 4 |a AIEgen 
650 4 |a aggregation function 
650 4 |a computed tomography 
650 4 |a imaging time window 
650 4 |a iodinated contrast agents 
650 7 |a Contrast Media  |2 NLM 
700 1 |a Zhu, Jingjing  |e verfasserin  |4 aut 
700 1 |a Wang, Shasha  |e verfasserin  |4 aut 
700 1 |a Zhao, Lingzhou  |e verfasserin  |4 aut 
700 1 |a Wei, Peng  |e verfasserin  |4 aut 
700 1 |a Yi, Tao  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 36(2024), 2 vom: 01. Jan., Seite e2309789  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:36  |g year:2024  |g number:2  |g day:01  |g month:01  |g pages:e2309789 
856 4 0 |u http://dx.doi.org/10.1002/adma.202309789  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 36  |j 2024  |e 2  |b 01  |c 01  |h e2309789